Related Experiment Video
Updated: Mar 15, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Alternative core development around the tetracyclic indole class of HCV NS5A inhibitors
Ling Tong1, Wensheng Yu1, Craig A Coburn1
1Merck Research Laboratories, 126 E. Lincoln Ave., Rahway, NJ 07065, USA.
Abstract:
Herein, we describe our research efforts to develop unique cores in molecules which function as HCV nonstructural protein 5A (NS5A) inhibitors. In particular, various fused tetracyclic cores were identified which showed genotype and mutant activities comparable to the indole-based tetracyclic core.
More Related Videos
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Subviral Agents
Dipeptidyl Peptidase 4 Inhibitors
Retroviruses
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

